infecti
viral
diseas
emerg
reemerg
pose
continu
health
threat
diseas
burden
human
sinc
increas
frequenc
infecti
outbreak
human
anim
observ
figur
human
mortal
recent
emerg
diseas
rang
peopl
due
infect
avian
influenza
viru
ten
million
peopl
due
acquir
immunodefici
syndrom
aid
emerg
viral
infect
larg
impact
livestock
product
well
caus
direct
mortal
depopul
polici
implement
protect
safeti
intern
trade
control
viru
spread
nearli
import
human
pathogen
either
zoonot
origin
zoonos
adapt
human
kuiken
et
al
smith
et
al
taylor
et
al
woolhous
gowtagesequeria
continu
bombard
novel
anim
pathogen
two
devast
pandem
human
histori
hivaid
spanish
influenza
start
interspeci
transmiss
caus
agent
de
wit
et
al
gao
et
al
hirsch
et
al
osterhau
recent
outbreak
infecti
diseas
among
sever
acut
respiratori
syndrom
sar
coronaviru
swine
influenza
viru
human
also
initi
transmiss
anim
host
human
highlight
problem
haagman
et
al
kuiken
et
al
smith
et
al
song
et
al
tang
et
al
appar
increas
transmiss
pathogen
anim
human
relat
plethora
acceler
environment
anthropogen
chang
increas
mobil
demograph
chang
alter
rate
natur
contact
anim
human
environment
chang
thought
play
role
recent
increas
distribut
arthropod
vector
aed
aegypti
led
larg
outbreak
dengu
fever
south
america
southeast
asia
weaver
reisen
intens
pig
farm
area
frugivor
bat
common
probabl
caus
introduct
nipah
viru
bat
pig
popul
malaysia
subsequ
transmiss
human
chua
origin
nonhuman
primat
chen
et
al
keel
et
al
marx
et
al
central
african
bush
hunter
infect
simian
foami
viru
wolf
et
al
consequ
increas
awar
ongo
systemat
global
effort
monitor
emerg
reemerg
pathogen
anim
human
need
haagman
et
al
kuiken
et
al
osterhau
wolf
et
al
surveil
viral
pathogen
anim
focu
domest
anim
wildlif
key
reservoir
speci
previous
shown
repres
immin
health
threat
human
human
popul
either
high
exposur
wild
domest
anim
hunter
butcher
veterinarian
zoo
worker
popul
high
suscept
immunocomprom
patient
would
key
target
monitor
novel
viral
pathogen
collect
effort
would
result
identif
divers
virus
human
expos
identif
anim
pathogen
may
threaten
us
futur
hope
earli
detect
human
subsequ
control
haagman
et
al
kuiken
et
al
wolf
et
al
may
even
possibl
predict
virus
like
cross
speci
barrier
chang
may
requir
evolut
anim
pathogen
humanspecif
pathogen
taken
togeth
effect
ration
approach
prevent
new
viral
epidem
human
anim
essenti
research
effort
mitig
effect
infecti
threat
focus
improv
surveil
diagnost
capabl
also
develop
intervent
strategi
vaccin
antivir
agent
crucial
genomicsbas
tool
potenti
candid
respond
challeng
recent
advanc
genomicsbas
tool
allow
sophist
understand
interact
among
gene
genet
pathway
environ
host
pathogen
alreadi
appar
genom
tool
start
chang
practic
medicin
exampl
use
assess
prognosi
guid
therapi
sever
form
cancer
stratifi
patient
accord
risk
longqt
syndrom
shed
light
respons
certain
drug
antiepilept
agent
priori
et
al
siddiqui
et
al
van
de
vijver
et
al
understand
live
organ
system
within
organ
interact
respond
environ
chang
dramat
genom
era
full
benefit
genom
tool
combat
viral
diseas
requir
understand
dynam
infect
regard
viral
divers
evolut
epidemiolog
combin
better
understand
pathogenesi
infect
molecular
basi
host
respons
infect
chapter
describ
genom
may
aid
mitig
viral
threat
highlight
potenti
role
limit
genom
approach
surveil
diagnost
develop
vaccin
antivir
figur
clinic
outcom
infecti
diseas
depend
properti
pathogen
host
distinct
made
viral
genom
host
genom
viral
genom
defin
studi
viral
genom
function
individu
gene
interact
gene
present
viral
genom
studi
involv
viral
genom
focu
viru
discoveri
divers
analys
turn
posit
influenc
develop
efficaci
surveil
tool
diagnost
vaccin
antivir
figur
viru
discoveri
often
start
identif
viral
diseas
entiti
subsequ
requir
identif
viral
pathogen
clinic
sampl
associ
diseas
presenc
viru
increas
sensit
detect
reduc
time
need
diagnosi
laboratori
today
increasingli
perform
viru
speciesspecif
viru
threat
pictur
show
viru
threat
worldwid
bocaviru
alland
et
al
polyomaviru
ki
alland
et
al
human
metapneumoviru
hmpv
van
den
hoogen
et
al
human
coronaviru
hcov
fouchier
et
al
van
der
hoek
et
al
nipah
viru
center
diseas
control
prevent
human
common
stool
associ
picornaviru
cosaviru
genotyp
kapoor
et
al
sar
coronaviru
drosten
et
al
hendra
viru
murray
et
al
polyomaviru
wu
gaynor
et
al
astroviru
finkbein
et
al
smit
et
al
swine
influenza
viru
garten
et
al
xenotrop
mulvrel
viru
xmrv
urisman
et
al
klasseviru
klasseviru
grening
et
al
ebola
viru
hall
hall
puumala
viru
tersago
et
al
human
tcell
lymphotrop
viru
htlv
calattini
et
al
wolf
et
al
molecular
assay
viru
identif
clinic
sampl
classic
method
use
identif
known
virus
includ
cell
culturebas
assay
immunolog
assay
molecular
detect
method
polymeras
chain
reaction
pcr
although
diagnost
assay
success
failur
rate
determin
etiolog
caus
diseas
signific
granerod
crowcroft
hajjeh
et
al
least
part
owe
limit
detect
diverg
virus
due
high
specif
assay
outbreak
pandem
influenza
viru
rapid
influenza
diagnost
test
ridt
wide
use
abil
quickli
detect
viral
antigen
respiratori
clinic
specimen
compar
studi
center
diseas
control
prevent
cdc
clinic
respiratori
specimen
previous
test
posit
pandem
season
influenza
viru
revers
transcriptas
rt
pcr
test
use
three
differ
ridt
tabl
rtpcr
assay
sensit
antigen
detect
assay
moreov
sensit
ridt
also
seem
vari
differ
influenza
viru
strain
center
diseas
control
prevent
failur
rate
determin
etiolog
caus
exampl
enceph
acut
flaccid
paralysi
non
ae
hepat
reportedli
granerod
crowcroft
saeed
et
al
chu
et
al
respect
rel
larg
proport
patient
suffer
diarrhea
finkbein
et
al
acut
respiratori
ill
juven
et
al
pathogen
could
detect
despit
use
wide
rang
sensit
diagnost
assay
mani
clinic
syndrom
virus
suspect
play
role
current
techniqu
fail
uncov
etiolog
agent
underlin
limit
even
best
current
methodolog
diagnosi
viral
infect
overal
fact
mani
acut
chronic
diseas
suspect
infecti
caus
still
unknown
etiolog
may
point
presenc
asyetunidentifi
virus
human
popul
appar
virusspecif
assay
current
use
routin
diagnost
set
equip
identif
new
previous
unrecogn
pathogen
modern
genomicsbas
laboratori
techniqu
gener
pcr
panvir
microarray
sequenceindepend
amplif
combin
highthroughput
sequenc
play
increasingli
import
role
viru
identif
discoveri
develop
pcr
sequenc
techniqu
seen
unpreced
increas
identif
character
viral
genom
led
develop
new
speciesspecif
diagnost
assay
virus
infect
anim
human
genomicsbas
approach
use
control
emerg
viru
diseas
diseas
develop
diagnost
vaccin
therapeut
inspir
seib
et
al
emerg
infecti
diseas
studi
viral
host
genom
perspect
viral
genom
aim
identif
character
virus
viru
divers
wherea
host
genom
focus
factor
influenc
host
respond
viral
infect
type
studi
reveal
target
diagnost
vaccin
therapeut
strategi
turn
use
surveil
prevent
treatment
diseas
still
use
routin
diagnost
set
also
allow
develop
gener
pcr
assay
pcr
assay
specif
broader
taxonom
rang
one
viru
speci
eg
whole
viru
genu
famili
assay
decreas
time
effort
demonstr
presenc
known
pathogen
clinic
sampl
although
sometim
expens
lose
sensit
compar
pcrbase
assay
target
singl
viru
speci
addit
assay
allow
identif
new
viru
speci
within
alreadyknown
viral
famili
demonstr
exampl
simian
homolog
human
herpesvirus
lacost
et
al
picornalik
virus
seawat
culley
steward
new
begomoviru
infect
corchoru
capsulari
plant
ha
et
al
astrovirus
roe
deer
smit
et
al
gener
pcr
assay
thu
provid
use
new
modern
genomicsbas
tool
viru
identif
surveil
diagnost
howev
limit
gener
pcr
assay
becom
readili
appar
complex
biolog
situat
diseas
caus
coinfect
differ
virus
diseas
etiolog
agent
identifi
also
virus
constantli
evolv
maximum
number
detect
virus
singl
assay
rel
low
diagnost
set
discrimin
subtyp
genera
virus
requir
addit
laborintens
procedur
final
diagnosi
limit
exist
viral
detect
methodolog
prompt
derisi
cowork
wang
et
al
devis
method
comprehens
unbias
analysi
viral
preval
given
biolog
set
use
genomicsbas
approach
viru
identif
develop
long
oligonucleotid
dna
microarray
potenti
simultan
detect
hundr
virus
shown
virus
repres
microarray
readili
detect
identifi
distinct
virus
explicitli
repres
microarray
distinct
hybrid
pattern
observ
differ
subtyp
virus
within
certain
famili
analyz
demonstr
abil
discrimin
subtyp
panvir
microarray
could
also
use
viru
discoveri
provid
new
virus
suffici
relat
alreadi
repres
microarray
permit
specif
hybrid
exampl
diagnost
set
use
panvir
microarray
shown
identif
human
parainfluenza
viru
immunocompet
adult
lifethreaten
acut
respiratori
ill
extens
panel
routin
clinic
diagnost
assay
fail
yield
diagnosi
chiu
et
al
outbreak
sar
presenc
previous
uncharacter
coronaviru
reveal
use
panvir
dna
microarray
wang
et
al
novel
gammaretroviru
xmrv
identifi
patient
prostat
tumor
homozyg
variant
rnase
l
urisman
et
al
although
panvir
microarray
consider
advantag
gener
pcr
assay
especi
term
broaderreach
less
bias
detect
virus
possibl
subtyp
virus
highli
diverg
virus
may
still
elud
identif
also
implement
standard
diagnost
assay
clinic
set
would
requir
establish
refer
librari
hybrid
signatur
hundr
individu
viral
subtyp
train
skill
laboratori
worker
read
viral
barcod
abil
creat
platform
method
costeffect
reproduc
barrier
may
hamper
largescal
clinic
use
method
know
speed
accuraci
effici
costeffect
dna
sequenc
improv
continu
sinc
introduct
longer
unrealist
sequenc
thousand
gene
singl
individu
suspect
viral
infect
therefor
next
gener
sequenc
techniqu
certain
import
advantag
panvir
microarray
use
combin
sequenceindepend
amplif
nucleic
acid
sequenceindepend
amplif
method
rel
simpl
fast
lack
bia
toward
viru
group
requir
specif
reagent
detect
new
virus
even
highli
diverg
alreadi
known
major
limit
method
limit
suitabl
sampl
host
nucleic
acid
viral
nucleic
acid
easili
separ
solid
tissu
tissu
biopsi
rel
contribut
host
nucleic
acid
compar
viral
nucleic
acid
extrem
larg
decreas
chanc
identif
viral
sequenc
even
use
nextgener
sequenc
platform
capabl
gener
sequenc
read
b
l
e
per
instrument
run
kuroda
et
al
key
viru
identif
sequenceindepend
amplif
method
increas
level
viral
nucleic
acid
reduc
background
nucleic
acid
gener
done
via
filtrat
centrifug
enzymat
remov
nonparticl
protect
nucleic
acid
delwart
alreadi
mani
new
virus
identifi
use
sequenceindepend
nucleic
acid
amplif
techniqu
alland
et
al
finkbein
et
al
fouchier
et
al
gaynor
et
al
jone
et
al
kapoor
et
al
kapoor
et
al
palacio
et
al
smit
et
al
van
der
hoek
et
al
van
leeuwen
et
al
victoria
et
al
viral
genom
analys
environment
collect
sampl
unmanipul
biolog
sampl
fecal
materi
show
high
divers
viral
commun
breitbart
et
al
breitbart
et
al
finkbein
et
al
venter
et
al
widescal
random
amplif
nucleic
acid
sequenc
becom
accept
medic
practic
howev
number
challeng
need
overcom
includ
develop
highthroughput
costeffect
reproduc
method
bioinformat
analyz
gener
data
train
skill
laboratori
worker
interpret
data
link
presenc
viru
sampl
diseas
delwart
servic
ten
bosch
grodi
case
new
virus
identifi
epidemiolog
studi
ultim
experiment
infect
studi
appropri
anim
model
requir
prove
identifi
viru
truli
causal
agent
infect
modern
genomicsbas
laboratori
techniqu
play
increasingli
import
role
surveil
identif
new
previous
unrecogn
pathogen
anim
human
provid
new
target
develop
viru
discoveri
tool
specif
diagnost
surveil
assay
vaccin
antivir
use
clinic
set
although
ongo
innov
genomicsbas
tool
would
aid
perfect
techniqu
allow
becom
standard
medic
practic
implement
routin
diagnost
set
await
sever
major
technic
breakthrough
improv
costeffect
analysi
result
genomicsbas
tool
use
viru
identif
character
also
allow
investig
pattern
viru
evolut
indepth
sequenc
viral
genom
individu
host
grow
evid
epidemiolog
infer
made
consensu
sequenc
popul
virus
within
individu
hide
inform
gener
phenotyp
divers
moreov
viral
lineag
identifi
individu
host
often
highli
diverg
suggest
evolv
host
via
mutat
antigen
drift
thu
clear
singl
individu
superinfect
multipl
viru
variant
may
major
consequ
develop
vaccin
intervent
strategi
present
full
genom
sequenc
major
human
pathogen
avail
viral
genom
complet
recent
year
advanc
sequenc
technolog
bioinformat
exponenti
growth
expect
sequenc
inform
virus
viral
quasispeci
individu
host
increas
avail
viral
genom
sequenc
allow
previous
unattain
rout
investig
phenomena
viral
pathogenesi
viru
evolut
develop
resist
treatment
vaccin
develop
illustr
hepat
c
viru
hcv
human
immunodefici
viru
hiv
continu
exert
substanti
diseas
burden
million
chronic
infect
patient
worldwid
virus
highli
genet
divers
within
individu
global
rambaut
et
al
simmond
simmond
et
al
hamper
prohibit
vaccin
develop
develop
effici
antivir
high
level
replic
errorpron
rnadepend
rna
polymeras
revers
transcriptas
enzym
hcv
hiv
respect
result
cloud
individu
quasispeci
sequenc
infect
person
minor
quasispeci
variant
resist
antivir
action
small
molecul
compound
readili
select
also
often
alreadi
present
quasispeci
swarm
becom
domin
therapi
recent
studi
examin
hcvinfect
patient
preexist
resist
mutat
development
antivir
compound
direct
nonstructur
protein
proteas
rnadepend
rna
polymeras
result
show
genotyp
patient
least
one
mutat
associ
resist
mutat
gaudieri
et
al
shimakami
cowork
comment
even
greater
frequenc
mutat
would
undoubtedli
discov
deeper
sequenc
method
risk
resist
diminish
use
combin
small
antivir
compound
although
vitro
studi
alreadi
show
doubleresist
mutant
select
albeit
often
associ
fit
cost
mo
et
al
similar
observ
made
hiv
infect
primari
drug
resist
mutat
patient
observ
patient
gupta
et
al
pared
clotet
sever
primari
resist
surveil
studi
use
sensit
genomicsbas
resist
assay
demonstr
increas
detect
variant
higher
primari
resist
rel
standard
populationbas
sequenc
metzner
et
al
pared
et
al
antiretrovir
therapi
remain
success
resistanceassoci
failur
therapi
must
prevent
identifi
primari
resist
tailor
antiretrovir
therapi
ensur
differ
compound
retain
full
antivir
activ
ensur
longterm
adher
patient
detect
failur
therapi
earli
identifi
emerg
resist
mutat
manag
failur
therapi
switch
new
antiretrovir
regimen
hirsch
genomicsbas
tool
aim
resist
detect
could
help
design
effect
person
antiretrovir
therapi
anoth
exampl
genomicsbas
approach
influenc
infecti
viral
diseas
prevent
method
come
influenza
viru
evolut
studi
comput
analys
sequenc
data
chang
view
influenza
viru
evolut
genom
data
reveal
genomewid
interact
critic
aspect
influenza
viru
evolut
shown
global
rise
resist
influenza
virus
adamantan
one
firstgener
antivir
bright
et
al
bright
et
al
surprisingli
rise
resist
also
observ
region
adamantan
rare
use
appar
resist
mutat
link
anoth
benefici
mutat
locat
elsewher
genom
simonsen
et
al
result
much
broader
spread
influenza
virus
carri
resist
mutat
genomicsbas
studi
also
confirm
import
reassort
influenza
viru
epidemiolog
evolut
sometim
result
gener
virus
alter
antigen
properti
vaccin
failur
holm
holm
et
al
raw
materi
reassort
provid
cocircul
multipl
often
divers
viral
lineag
subtyp
given
popul
holm
holm
et
al
nelson
et
al
global
sourc
popul
human
influenza
virus
locat
southeast
asia
ignit
season
influenza
epidem
rest
world
rambaut
et
al
russel
et
al
global
influenza
surveil
network
routin
character
genet
antigen
properti
influenza
virus
latter
mainli
use
classic
hemagglutin
inhibit
assay
bind
assay
base
abil
influenza
virus
agglutin
red
blood
cell
one
surfac
protein
hemagglutinin
ha
abil
antisera
rais
relat
strain
block
agglutin
combin
sequenc
inform
immunogen
domain
epidemiolog
data
antigen
data
use
select
strain
vaccin
season
epidem
influenza
smith
et
al
fact
sourc
popul
human
influenza
virus
known
crucial
vaccin
develop
vaccin
fail
due
period
acceler
antigen
evolut
expect
genet
data
smith
et
al
know
variant
gener
intens
survey
geograph
area
aid
formul
vaccin
strain
futur
genomicsbas
studi
influenza
viru
variabl
combin
compar
patholog
studi
may
unravel
exampl
whether
genet
basi
observ
differ
clinic
present
influenza
human
thu
viru
divers
studi
impact
vaccin
efficaci
antivir
efficaci
resist
challeng
futur
viru
divers
evolut
studi
integr
viral
genom
data
clinic
symptom
sign
patholog
vaccin
develop
antivir
resist
studi
advanc
genomicsbas
tool
combin
increas
amount
indepth
analysi
individu
sampl
patient
mild
sever
ill
may
allow
priori
risk
assess
regard
sever
diseas
may
guid
vaccin
therapi
option
mention
previous
implement
method
routin
diagnost
set
make
necessari
take
larg
hurdl
futur
common
knowledg
immun
statu
age
nutrit
statu
mani
factor
play
import
role
clinic
outcom
viral
infect
underlin
import
studi
host
pathogen
paramet
genom
tool
battl
viral
infect
follow
complet
human
genom
project
investig
underli
herit
mutat
capabl
induc
increas
suscept
diseas
becom
possibl
mutat
explain
patienttopati
differ
patholog
contrast
analyz
patient
dna
gene
express
profil
examin
express
mani
differ
rna
andor
protein
integr
impact
dnabas
effect
varieti
factor
includ
viral
infect
modul
cellular
respons
analys
lead
complet
understand
mechan
contribut
patholog
drive
develop
new
diagnost
therapeut
strategi
figur
underli
mechan
mani
diseas
effici
treatment
remain
obscur
also
remain
larg
unknown
host
factor
influenc
viral
life
cycl
genom
research
offer
new
opportun
determin
diseas
occur
character
molecular
abnorm
underli
diseas
process
identifi
host
gene
requir
viral
replic
latter
done
perform
genomewid
function
screen
use
small
interf
rna
sirna
interfer
express
specif
gene
infecti
vitro
cultur
system
genomewid
associ
studi
gwa
use
identifi
gene
associ
diseas
survey
genet
variat
typic
hundr
thousand
singl
nucleotid
polymorph
snp
patient
without
given
diseas
perform
identifi
variant
snp
found
significantli
commonli
patient
diseas
compar
diseasefre
control
mani
snp
associ
wide
rang
diseas
characterist
describ
cooper
et
al
gudbjartsson
et
al
liu
et
al
miyagawa
et
al
exampl
differ
herit
mutat
involv
develop
primari
cardiomyopathi
identifi
estim
snp
respons
hypertroph
cardiomyopathi
marguli
et
al
assay
screen
cardiomyopathycaus
mutat
affect
patient
avail
likelihood
detect
genet
basi
patient
hypertroph
dilat
cardiomyopathi
marguli
et
al
like
increas
mutat
identifi
ultim
type
assay
access
clinician
identifi
patient
famili
member
increas
risk
diseas
possibl
prevent
modul
diseas
progress
diseasemodifi
therapi
despit
enorm
impact
viral
infect
human
health
rel
gwa
perform
success
identifi
diseas
suscept
variant
viral
infect
perhap
surprisingli
studi
done
concern
chronic
often
lifelong
infect
hiv
hcv
recent
shown
sever
snp
locat
near
gene
significantli
common
hcv
patient
respond
interferon
therapi
nonrespond
ge
et
al
suppiah
et
al
tanaka
et
al
suggest
genet
basi
effici
antihcv
therapi
although
diagnost
test
identifi
like
respond
interferon
therapi
may
futur
possibl
clinic
decisionmak
difficult
effect
advantag
snp
absolut
altern
interferon
therapi
exist
fellay
cowork
use
gwa
determin
viral
load
prior
onset
aid
differ
five
log
individu
patient
identifi
polymorph
associ
hla
loci
b
c
conclud
major
determin
differ
circul
viral
load
fellay
et
al
moreov
data
underlin
import
carri
similar
studi
chronic
perhap
also
acut
infecti
diseas
initi
studi
sever
other
implic
loci
influenc
viral
load
progress
infect
aid
loeuillet
et
al
pelak
et
al
remark
gene
critic
hiv
infect
detect
show
difficulti
impos
strict
statist
test
although
allow
discoveri
new
gene
also
guarante
mani
true
associ
miss
process
avoid
falseposit
associ
winkler
anoth
method
develop
find
hiv
hcv
depend
factor
sirna
genomewid
function
screen
brass
et
al
li
et
al
approach
sirna
use
knock
gene
one
one
cell
line
support
hiv
hcv
replic
assay
mani
hiv
hcv
depend
factor
influenc
viral
replic
identifi
factor
requir
cell
viabil
excel
genet
stabl
candid
antivir
drug
note
host
gene
need
hiv
replic
also
import
hcv
replic
could
exploit
case
coinfect
addit
sever
identifi
hcv
depend
factor
found
requir
replic
two
member
flavivirida
famili
west
nile
viru
dengu
viru
krishnan
et
al
particl
format
multipl
virus
includ
marburg
ebola
measl
virus
murray
et
al
shisheva
sirna
screen
howev
limit
identif
cellular
gene
moreov
effect
diseas
identifi
gene
product
infect
popul
remain
unknown
similar
function
genom
experi
perform
identifi
host
cell
factor
temporarili
dispens
host
crucial
viru
replic
broad
rang
influenza
virus
includ
highli
pathogen
avian
pandem
virus
prusti
et
al
host
factor
provid
promis
new
antivir
target
block
allevi
downstream
effect
pathogen
infect
overal
gwa
genomewid
function
screen
shown
elucid
biomark
diseas
risk
provid
new
biolog
insight
pathophysiolog
process
clarifi
known
risk
factor
predispos
diseas
develop
discov
host
gene
requir
replic
virus
fulli
interpret
result
futur
studi
data
incorpor
function
express
experi
virusmedi
chang
gene
express
ge
et
al
insight
obtain
type
studi
may
use
develop
intervent
strategi
hold
promis
person
medicin
link
individu
genet
inform
diseas
prevent
therapi
respons
highli
interest
differ
virus
share
need
certain
host
protein
replic
vitro
defin
host
factor
pathway
upon
multipl
virus
depend
could
aid
develop
common
intervent
strategi
applic
larg
number
viral
infect
outcom
viral
infect
depend
much
viral
host
properti
scientist
use
wide
array
method
studi
virus
interact
host
mechan
host
protect
virus
develop
express
microarray
highthroughput
genom
proteom
techniqu
abil
character
key
interact
host
pathogen
greatli
increas
unravel
possibl
develop
diagnost
assay
multitarget
therapi
design
limit
viru
replic
mitig
immunopatholog
andeweg
et
al
treatment
may
even
tailor
target
host
respons
pathway
common
mani
viru
infect
could
use
earli
infect
accur
diagnosi
yet
avail
although
express
profil
experi
perform
mani
differ
virus
includ
hiv
hcv
sar
coronaviru
influenza
viru
dengu
west
nile
exampl
discuss
show
princip
applic
genom
proteomicsbas
tool
studi
infect
differ
pathogen
virus
dengu
viru
infect
global
public
health
problem
caus
million
case
dengu
fever
df
yearli
result
clinic
case
lifethreaten
dengu
hemorrhag
fever
syndrom
dhf
df
dhf
patient
display
similar
clinic
pictur
earli
infect
endem
area
outbreak
dengu
case
capac
medic
assist
limit
earli
discrimin
df
patient
patient
risk
develop
dhf
would
allow
effect
alloc
medic
attent
recent
studi
use
genomicsbas
tool
wellcharacter
cohort
dengu
patient
aim
obtain
insight
earli
immun
mechan
associ
dengu
sever
identifi
biomark
predict
infect
outcom
result
suggest
df
dhf
extrem
continuum
diseas
two
separ
diseas
nascimento
et
al
sierra
et
al
set
gene
identifi
upon
quantif
pcr
assay
first
medic
visit
dengu
virusinfect
patient
could
use
predict
whether
patient
develop
dhf
symptom
coupl
day
later
nascimento
et
al
peripher
blood
gene
express
signatur
identifi
accur
distinguish
individu
symptomat
acut
respiratori
infect
uninfect
individu
addit
gene
express
signatur
distinguish
individu
respiratori
viral
infect
bacteri
infect
even
distinguish
individu
respiratori
viral
infect
caus
human
rhinoviru
influenza
viru
respiratori
syncyti
viru
zaa
et
al
thu
gene
express
profil
may
serv
use
diagnost
test
tailor
treatment
acut
respiratori
infect
could
enhanc
tradit
diagnost
assay
individu
treatment
chronic
hepat
c
virusinfect
patient
unbias
proteom
profil
use
identifi
host
predictor
virolog
respons
interferonbas
therapi
serumbas
protein
signatur
identifi
could
accur
predict
whether
chronic
hcvinfect
patient
would
respond
standardofcar
interferonbas
therapi
prior
treatment
patel
et
al
interferonbas
therapi
associ
signific
side
effect
half
treat
subject
respond
rel
expens
therapi
accur
predict
antivir
efficaci
import
tool
proper
tailor
individu
treatment
process
gene
express
profil
studi
simian
immunodefici
viru
siv
infect
natur
nonnatur
host
provid
uniqu
view
host
respons
influenc
lentivir
infect
outcom
mani
nonhuman
primat
speci
subsaharan
africa
infect
siv
natur
reservoir
host
develop
aid
result
infect
appear
live
normal
lifespan
contrast
nonnatur
host
asian
pigtail
macaqu
develop
aid
manner
similar
hivinfect
human
sodora
et
al
acut
infect
natur
nonnatur
host
viru
replic
peak
within
week
infect
high
viral
load
remain
chronic
phase
infect
long
remain
unclear
natur
host
could
sustain
high
viral
load
without
develop
diseas
gene
express
profil
pathogen
nonpathogen
siv
infect
model
reveal
strong
type
interferon
respons
initi
induc
model
resolv
peak
viral
load
nonpathogen
siv
infect
model
natur
host
also
exhibit
better
preserv
overal
cell
homeostasi
lower
level
immun
activ
progress
deplet
cell
preserv
mucos
cell
bosing
et
al
favr
et
al
jacquelin
et
al
leder
et
al
sodora
et
al
result
suggest
activ
immun
downregulatori
mechan
rather
intrins
attenu
immun
respons
mandl
et
al
underli
low
level
immun
activ
coexist
siv
infect
without
progress
aid
human
longterm
asymptomat
hivinfect
patient
high
viral
load
low
immun
activ
statu
describ
seem
underscor
studi
natur
reservoir
nonhuman
primat
host
choudhari
et
al
data
show
supposedli
longstand
evolutionari
coadapt
primat
lentivirus
natur
reservoir
host
allow
coexist
viru
host
may
eventu
also
occur
human
choudhari
et
al
sodora
et
al
importantli
genomicsbas
studi
sivinfect
natur
nonnatur
host
show
futur
research
focu
identifi
mechan
respons
chronic
immun
activ
devis
immunomodulatori
strategi
prevent
zoonot
transmiss
sar
coronaviru
caus
outbreak
sever
acut
respiratori
syndrom
pneumon
diseas
human
overal
mortal
rate
clinic
cours
outcom
sar
coronavirusassoci
diseas
favor
children
compar
adolesc
adult
hon
et
al
leung
chiu
wong
et
al
elderli
patient
poor
prognosi
mortal
rate
peiri
et
al
peiri
et
al
predisposit
diseas
also
shown
age
young
cynomolgu
macaqu
experiment
infect
sar
coronaviru
age
macaqu
show
significantli
lung
patholog
upon
infect
young
adult
macaqu
smit
et
al
gene
express
profil
studi
reveal
age
macaqu
display
promin
host
respons
infect
young
adult
macaqu
increas
differenti
express
gene
associ
inflamm
wherea
type
interferon
express
reduc
observ
trigger
anoth
experi
age
macaqu
therapeut
treat
type
interferon
infect
reduc
patholog
proinflammatori
gene
express
without
affect
viru
replic
level
clinic
manifest
sar
coronavirusassoci
diseas
highli
similar
acut
lung
injuri
caus
multipl
pathogen
condit
includ
sepsi
gastric
acid
aspir
pulmonari
infect
avian
influenza
viru
multipl
host
speci
conserv
injuri
pathway
propos
imai
et
al
assum
conserv
injuri
pathway
induc
multipl
trigger
includ
pandem
influenza
virus
modul
host
respons
type
interferon
provid
promis
outlook
novel
intervent
strategi
smit
et
al
recent
studi
african
green
monkey
howev
indic
distinct
sar
coronavirusinduc
acut
lung
injuri
pathway
may
exist
differ
host
speci
need
taken
account
analyz
intervent
strategi
speci
smit
et
al
microarray
express
profil
studi
also
use
determin
newli
emerg
zoonot
influenza
viru
infect
often
caus
sever
diseas
season
epidem
influenza
virus
use
genet
engin
influenza
virus
shown
protein
deriv
spanish
pandem
influenza
viru
block
express
host
antivir
respons
effici
protein
establish
season
influenza
viru
geiss
et
al
studi
mice
macaqu
genet
engin
influenza
virus
contain
gene
segment
viru
pathogen
avian
influenza
viru
suggest
highli
pathogen
influenza
virus
induc
sever
diseas
aberr
persist
activ
proinflammatori
cytokin
chemokin
respons
baskin
et
al
kash
et
al
kash
et
al
kobasa
et
al
ferret
shown
infect
influenza
viru
induc
sever
diseas
strong
express
among
other
treatment
antagonist
receptor
reduc
sever
symptom
viral
titer
compar
control
anim
cameron
et
al
experi
show
comparison
differ
virus
strain
respect
impact
host
gene
express
could
lead
develop
therapeut
intervent
also
could
aid
predict
pathogen
new
past
viru
strain
use
highthroughput
profil
techniqu
geiss
et
al
overal
gene
express
profil
studi
viral
infect
provid
insight
pathophysiolog
process
elucid
biomark
diseas
risk
allow
knowledgeguid
develop
host
responsemodul
therapeut
treatment
futur
effort
focu
compar
contrast
outcom
infect
close
relat
virus
differ
host
speci
delin
variou
host
pathway
viral
trait
caus
differ
diseas
outcom
integr
genomicsproteom
data
obtain
differ
virus
differ
host
could
potenti
elucid
common
host
pathway
involv
develop
patholog
allow
ration
design
diagnost
assay
hostmodul
antipatholog
strategi
applic
larg
number
viral
infect
clear
genomicsbas
tool
obtain
firm
foothold
mani
scientif
disciplin
combat
viral
infect
either
establish
newli
emerg
genomicsbas
tool
predominantli
appli
identif
diagnosi
viral
infect
viru
divers
studi
gwa
genomewid
function
screen
host
gene
express
profil
studi
deliv
new
target
viral
host
origin
develop
diagnost
surveil
assay
vaccin
therapeut
figur
corpor
perspect
larg
popul
patient
could
benefit
vaccin
therapeut
agent
becom
financi
interest
produc
true
person
treatment
singl
individu
difficult
accomplish
thu
identifi
biomark
assay
hostmodifi
treatment
work
andor
broad
spectrum
differ
virus
utmost
import
compar
studi
dynam
infect
regard
viral
divers
evolut
epidemiolog
combin
molecular
basi
host
respons
infect
pathogenesi
may
enabl
ration
design
multipot
biolog
respons
modifi
mitig
effect
viral
diseas
focus
broadact
intervent
strategi
surveil
new
viral
pathogen
may
better
prepar
outbreak
newli
emerg
infecti
diseas
realiz
full
potenti
genomicsbas
tool
data
clinic
set
sever
major
obstacl
need
overcom
one
method
need
costeffect
highthroughput
format
although
contempl
within
two
decad
possibl
sequenc
anyon
entir
genom
less
may
complic
ethic
legal
social
societ
issu
exist
dna
sequenc
andor
method
intellectu
properti
claim
may
impact
develop
multigen
diagnost
test
chandrasekharan
cookdeegan
addit
although
seemingli
farfetch
present
privaci
measur
regard
genet
inform
need
enact
sign
law
prevent
abus
data
exampl
insur
employ
may
one
day
becom
realist
situat
secondli
larg
invest
bioinformat
tool
databas
data
manag
requir
make
optim
use
gener
data
thirdli
clinic
diagnosi
diseas
larg
chang
use
genomicsbas
tool
becom
standard
oper
procedur
molecular
diagnostician
need
gain
experi
interpret
data
gener
radic
differ
rapidli
evolv
techniqu
howev
mani
molecular
biolog
tool
found
way
clinic
set
reason
genomicsbas
tool
could
transit
research
set
clinic
futur
despit
hurdl
need
overcom
ten
bosch
grodi
